Literature DB >> 26559089

MicroRNA-34 Family and Its Role in Cardiovascular Disease.

Na Li1, Kun Wang1, Pei-Feng Li1.   

Abstract

MicroRNAs (miRNAs) have been considered important regulators in both physiological and disease contexts. Among all miRNAs, the miR-34 family (miR-34a, -34b, -34c), which has been well characterized as a tumor suppressor, displays diverse functions in noncancerous diseases. MiR-34 levels are relatively low in the cardiovascular system, but recently they have been reported to function in cardiovascular disorders by regulating apoptosis, telomere attrition, DNA damage, and inflammatory response. In this review, we mainly summarize their roles in cardiac senescence and ischemic diseases.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26559089     DOI: 10.1615/critreveukaryotgeneexpr.2015015396

Source DB:  PubMed          Journal:  Crit Rev Eukaryot Gene Expr        ISSN: 1045-4403            Impact factor:   1.807


  15 in total

1.  Circular RNA circDENND2A protects H9c2 cells from oxygen glucose deprivation-induced apoptosis through sponging microRNA-34a.

Authors:  Yuanxia Shao; Peng Zhong; Li Sheng; Hongjian Zheng
Journal:  Cell Cycle       Date:  2019-12-27       Impact factor: 4.534

2.  Comparative co-expression analysis of RNA-Seq transcriptome revealing key genes, miRNA and transcription factor in distinct metabolic pathways in diabetic nerve, eye, and kidney disease.

Authors:  Veeran Kutty Subaida Shafna Asmy; Jeyakumar Natarajan
Journal:  Genomics Inform       Date:  2022-09-30

Review 3.  The Epigenetic Role of MiRNAs in Endocrine Crosstalk Between the Cardiovascular System and Adipose Tissue: A Bidirectional View.

Authors:  Ursula Paula Reno Soci; Bruno Raphael Ribeiro Cavalcante; Alex Cleber Improta-Caria; Leonardo Roever
Journal:  Front Cell Dev Biol       Date:  2022-07-04

4.  MicroRNA-34a targets sirtuin 1 and leads to diabetes-induced testicular apoptotic cell death.

Authors:  Dan Jiao; Huan Zhang; Ziping Jiang; Wenlin Huang; Zhuo Liu; Zhaohui Wang; Yonggang Wang; Hao Wu
Journal:  J Mol Med (Berl)       Date:  2018-07-21       Impact factor: 4.599

Review 5.  Oxidative Stress and Cellular Response to Doxorubicin: A Common Factor in the Complex Milieu of Anthracycline Cardiotoxicity.

Authors:  Donato Cappetta; Antonella De Angelis; Luigi Sapio; Lucia Prezioso; Michela Illiano; Federico Quaini; Francesco Rossi; Liberato Berrino; Silvio Naviglio; Konrad Urbanek
Journal:  Oxid Med Cell Longev       Date:  2017-10-18       Impact factor: 6.543

6.  MiR34 inhibition induces human heart progenitor proliferation.

Authors:  Gioacchin Iannolo; Maria Rita Sciuto; Giuseppe Maria Raffa; Michele Pilato; Pier Giulio Conaldi
Journal:  Cell Death Dis       Date:  2018-03-06       Impact factor: 8.469

7.  Circulating microRNAs as biomarkers of disease and typification of the atherothrombotic status in antiphospholipid syndrome.

Authors:  Carlos Pérez-Sánchez; Iván Arias-de la Rosa; María Ángeles Aguirre; María Luque-Tévar; Patricia Ruiz-Limón; Nuria Barbarroja; Yolanda Jiménez-Gómez; María Carmen Ábalos-Aguilera; Eduardo Collantes-Estévez; Pedro Segui; Francisco Velasco; María Teresa Herranz; Jesús Lozano-Herrero; María Julia Hernandez-Vidal; Constantino Martínez; Rocío González-Conejero; Massimo Radin; Savino Sciascia; Irene Cecchi; María José Cuadrado; Chary López-Pedrera
Journal:  Haematologica       Date:  2018-03-15       Impact factor: 9.941

Review 8.  Endothelial Cell Aging: How miRNAs Contribute?

Authors:  Munekazu Yamakuchi; Teruto Hashiguchi
Journal:  J Clin Med       Date:  2018-07-10       Impact factor: 4.241

9.  MiR-1298 affects cell proliferation and apoptosis in C6 cells by targeting SET domain containing 7.

Authors:  Chun-Mei Wang; Bao-Hua Cheng; Qing-Jie Xue; Jing Chen; Bo Bai
Journal:  Int J Immunopathol Pharmacol       Date:  2017-08-01       Impact factor: 3.219

Review 10.  Regulation of Long Non-coding RNAs and MicroRNAs in Heart Disease: Insight Into Mechanisms and Therapeutic Approaches.

Authors:  Lucy Collins; Pablo Binder; Hongshan Chen; Xin Wang
Journal:  Front Physiol       Date:  2020-07-10       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.